,i  #aai? ,,congress  #a/ ,session  ,h4 
,r4 #chgc  ,,9 ,,! ,,h\se ,,(           
,,repres5tatives  ,june #aj1 #bjbe,mr4  
,fitzpatrick 7= himself & ,mrs4 ,d+ell7 
introduc$ ! foll[+ bill2 :i* 0 ref]r$ to
 ! ,committee on ,appropriations1 & 9   
addition to ! ,committee on ,en]gy &    
,comm]ce1 = a p]iod to be subsequ5tly   
det]m9$ by ! ,speak]1 9 ea* case =      
consid]ation ( su* provisions z fall )9 
! jurisdiction ( ! committee conc]n$  ,a
 ,,bill  ,to increase fund+ = canc]     
rese>* by ! ,national ,canc] ,in/itute  
to be m 9 proportion to ! mortality     
rates ( canc]4  #a4 ,%ort title ,?is    
,act may be cit$ z ! ,knock ,out ,canc] 
,act or ! ,,ko ,canc] ,act4  #b4 ,f9d+s 
,congress f9ds ! foll[+3  7#a7 ,canc] is
 "o ( ! lead+ causes ( dea? 9 ! _w & has
 t\*$ ne>ly e life1 ei!r directly or    
indirectly4  7#b7 ,canc] is ! cause (   
ne>ly #a out ( e #d dea?s 9 ! ,unit$    
,/ates1 s9ce #bjjj total+ ov] #ae       
million ,am]ican lives4  7#c7 ,ef=ts to 
increase aw>5ess ( canc] symptoms among 

pati5ts & cl9icians w\ld lead to e>li]  
detection & improvem5ts 9 survival      
rates4  7#d7 ,sci5tific und]/&+ & rese>*
 lead to innovations 9 effective        
treatm5ts1 controls1 & cures = canc]4   
7#e7 ,! ,national ,canc] ,in/itute has  
be5 a lead] 9 f9d+ m$ical break?r\ghs = 
treatm5t & !rapies = canc] pati5ts4     
7#f7 ,?r\gh sub/antial inve/m5t 9 canc] 
rese>*1 pot5tially ev5 ! tripl+ (       
necess>y fund+1 ! ,unit$ ,/ates w be be/
 able to address ! mortality rates (    
canc] & ! impacts on ! pati5t           
population4  #c4 ,increas+ ,,nci budget 
= canc] rese>* ,to conduct or support   
canc] rese>*1 !re is h]eby appropriat$1 
= ea* ( fiscal ye>s #bjbf ?r\gh #bjcj1  
to ! ,national ,canc] ,in/itute1 out (  
am\nts 9 ! ,treasury n o!rwise          
appropriat$1 an am\nt t is equal to #be 
p]c5t ( ! total am\nt appropriat$ to !  
,national ,canc] ,in/itute = fiscal ye> 
#bjbb1 to rema9 available until exp5d$4 
,am\nts appropriat$ pursuant to ! prec$+
 s5t5ce %all be 9 addition to am\nts    

o!rwise made available to ! ,national   
,canc] ,in/itute4  #d4 ,report to       
,congress on canc] drug %ortages  7a7   
,/udy ,! ,secret>y ( ,heal? & ,human    
,s]vices1 act+ ?r\gh ! ,commission] (   
,food & ,drugs1 9 collaboration ) su*   
o!r ag5cies z ! ,secret>y deems         
necess>y1 %all /udy ! reasons = canc]   
drug %ortages1 includ+--  7#a7 economic 
reasons2  7#b7 supply *a9 failures2     
7#c7 delays & o!r complications relat+  
to-- 7,a7 ! developm5t ( canc] drugs2 & 
7,b7 ! approval ( su* drugs by ! ,food &
 ,drug ,adm9i/ration2 &  7#d7           
insuffici5t g5]ic drugs & biosimil>     
biological products4  7b7 ,report  7#a7 
,9 g5]al ,n lat] ?an #a ye> aft] ! date 
( enactm5t ( ?is ,act1 ! ,secret>y (    
,heal? & ,human ,s]vices1 act+ ?r\gh !  
,commission] ( ,food & ,drugs1 %all     
complete ! /udy "u subsection 7a7 &     
submit a report to ! appropriate        
committees ( ! ,congress on ! results ( 
su* /udy4  7#b7 ,recomm5dations ,!      
report "u p>agraph 7#a7 %all include    

recomm5dations = address+ ! reasons =   
canc] drug %ortages4